# \[Treatment of acromegaly with sustained-release lanreotide. A new somatostatin analog\].

> PubMed lists PMID 8099735 in Presse medicale (Paris, France : 1983) as Journal Article, with publication-date metadata of 1993-03-27 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-8099735-lanreotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2016-12-09
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-8099735-lanreotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8099735-lanreotide-v1.json
- Content SHA-256: `521d929eaf5487623ac33123a25ec478b9849f3275ce034ebca203bd9f615aef`

## Claims and source pins

### Headline

\[Treatment of acromegaly with sustained-release lanreotide. A new somatostatin analog\]. ([`pubmed-observation-pmid-8099735-2016-12-09-c79dc4a68c38`](#source-pubmed-observation-pmid-8099735-2016-12-09-c79dc4a68c38))

### Summary

PubMed lists PMID 8099735 in Presse medicale (Paris, France : 1983) as Journal Article, with publication-date metadata of 1993-03-27 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-8099735-2016-12-09-c79dc4a68c38`](#source-pubmed-observation-pmid-8099735-2016-12-09-c79dc4a68c38))

### Paragraph 1

PubMed lists PMID 8099735 in Presse medicale (Paris, France : 1983) as Journal Article, with publication-date metadata of 1993-03-27 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-8099735-2016-12-09-c79dc4a68c38`](#source-pubmed-observation-pmid-8099735-2016-12-09-c79dc4a68c38))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-8099735-2016-12-09-c79dc4a68c38`](#source-pubmed-observation-pmid-8099735-2016-12-09-c79dc4a68c38))

## Sources

<a id="source-pubmed-observation-pmid-8099735-2016-12-09-c79dc4a68c38"></a>
- **\[Treatment of acromegaly with sustained-release lanreotide. A new somatostatin analog\]. · retained source version 1:2016-12-09:current:c79dc4a68c382253ef4da8fcee618d6ad13bb2dabb894870643120d36a3f21e6** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/8099735/) (`pubmed-observation-pmid-8099735-2016-12-09-c79dc4a68c38`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "\[Treatment of acromegaly with sustained-release lanreotide. A new somatostatin analog\]." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8099735-lanreotide-v1.json SHA-256: 521d929eaf5487623ac33123a25ec478b9849f3275ce034ebca203bd9f615aef.